Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat

The Journal of Clinical Investigation
C C TsengM M Wolfe

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is a 42-amino acid peptide produced by K cells of the mammalian proximal small intestine and is a potent stimulant of insulin release in the presence of hyperglycemia. However, its relative physiological importance as a postprandial insulinotropic agent is unknown. Using LGIPR2 cells stably transfected with rat GIP receptor cDNA, GIP (1-42) stimulation of cyclic adenosine monophosphate (cAMP) production was inhibited in a concentration-dependent manner by GIP (7-30)-NH2. Competition binding assays using stably transfected L293 cells demonstrated an IC50 for GIP receptor binding of 7 nmol/liter for GIP (1-42) and 200 nmol/liter for GIP (7-30)-NH2, whereas glucagonlike peptide-1 (GLP-1) binding to its receptor on ++betaTC3 cells was minimally displaced by GIP (7-30)-NH2. In fasted anesthetized rats, GIP (1-42) stimulated insulin release in a concentration-dependent manner, an effect abolished by the concomitant intraperitoneal administration of GIP (7-30)-NH2 (100 nmol/ kg). In contrast, glucose-, GLP-1-, and arginine-stimulated insulin release were not affected by GIP (7-30)-NH2. In separate experiments, GIP (7-30)-NH2 (100 nmol/kg) reduced postprandial insulin release in consci...Continue Reading

References

Mar 1, 1992·European Journal of Clinical Investigation·E G SiegelW Creutzfeldt
Nov 1, 1990·Journal of Pharmacological Methods·Z X Xu, S Melethil
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S EfratS Baekkeskov
Aug 1, 1988·Regulatory Peptides·K ShimaC Ohboshi
Aug 1, 1988·Mayo Clinic Proceedings·L T ShusterF J Service
Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Aug 1, 1986·The Journal of Clinical Endocrinology and Metabolism·M A NauckW Creutzfeldt
Jan 1, 1987·Diabetes/metabolism Reviews·R Ebert, W Creutzfeldt
Apr 1, 1987·Scandinavian Journal of Clinical and Laboratory Investigation·C Orskov, J J Holst
Aug 1, 1985·Diabetologia·W Creutzfeldt, R Ebert
Nov 1, 1973·The Journal of Clinical Endocrinology and Metabolism·J DupreJ C Brown
Mar 1, 1969·Archives of Internal Medicine·R H Unger, A M Eisentraut
Jan 1, 1983·The Journal of Investigative Dermatology·N H Rubin, L E Scheving
Jan 1, 1995·The Journal of Clinical Investigation·Z WangS R Bloom
Dec 1, 1993·Canadian Journal of Physiology and Pharmacology·T J KiefferR A Pedersen
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C C TsengM M Wolfe

❮ Previous
Next ❯

Citations

Dec 7, 2002·Diabetes/metabolism Research and Reviews·Jens Juul Holst
Sep 17, 2003·Current Diabetes Reports·Bo Ahrén
Feb 27, 2004·European Journal of Pharmacology·Kotaro TakasakiKatsuya Higo
Mar 12, 2003·Trends in Pharmacological Sciences·Timothy J Kieffer
Jul 26, 2002·Regulatory Peptides·Juris J MeierBaptist Gallwitz
May 30, 2001·Molecular and Cellular Endocrinology·R J BollagC M Isales
Aug 22, 2009·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Mayte Alvarez CrespoFederico Mallo Ferrer
Jul 28, 2001·Diabetes Technology & Therapeutics·R PerfettiS Busselen
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Sep 17, 2010·Science Translational Medicine·Rohit N Kulkarni
Oct 2, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Michelle C MussonM Michael Wolfe
Jan 4, 2007·The Journal of Clinical Investigation·Daniel J Drucker
Apr 29, 2003·Biological Chemistry·Simon A HinkeChristopher H S McIntosh
Mar 19, 2003·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Juris J MeierMichael A Nauck
Dec 3, 2010·The Journal of Nutrition·Mark A PereiraAnthony D Pellegrini
May 17, 2011·Acta Diabetologica·Gian Paolo FadiniAngelo Avogaro
Jul 8, 2009·Diabetologia·J M García-MartínezC García-Jiménez
Mar 12, 2004·Expert Opinion on Investigational Drugs·Torsten P Vahl, David A D'Alessio
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Jul 15, 2009·Trends in Endocrinology and Metabolism : TEM·Rhonda D Wideman, Timothy J Kieffer
Jul 2, 2011·British Journal of Pharmacology·Sebastian G B FurnessPatrick M Sexton
Jul 6, 2014·Diabetes/metabolism Research and Reviews·Hale M TasyurekSalih Sanlioglu
Nov 10, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Juris J Meier, Michael A Nauck
Apr 4, 2016·Trends in Molecular Medicine·Brian FinanMatthias H Tschöp
Jul 5, 2011·Regulatory Peptides·Michelle C MussonM Michael Wolfe
Mar 6, 2010·International Dairy Journal·Frank Reimann
Oct 17, 2015·Journal of Diabetes and Metabolic Disorders·Alok SharmaArchana Tiwari
Mar 7, 2006·Cell Metabolism·Daniel J Drucker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.